Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -6.23 | 24.50 |
PEG Ratio (TTM) | -0.31 | 2.33 |
P/S Ratio (TTM) | 1.92 | 5.42 |
P/B Ratio (TTM) | 0.41 | 5.06 |
P/FCF Ratio (TTM) | -25.15 | 11.26 |
Price to 5YR AVG Earnings Ratio | -1.66 | 5.17 |
Price to 5YR AVG FCF Ratio | -13.55 | 23.99 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.29% | 3.20% |
ROE (TTM) | -6.77% | 31.38% |
Net Profit Margin (TTM) | -29.07% | -10.10% |
ROIC 5YR AVG | -7.10% | 10.85% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 14.97% | -331.76% | -213.88% |
Revenue | 6.21% | 58.94% | 40.48% |
Net Income | 10.56% | -293.42% | -205.93% |
Cash Flow | 28.11% | -125.81% | -152.77% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.27 | 2.49 |
Quick Ratio (TTM) | 1.42 | 1.83 |
D/E Ratio (TTM) | 0.09 | -0.01 |
Interest Coverage (TTM) | -2.64 | 12.09 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 0.29 | 4.74 |
LTL to 5YR AVG FCF | -2.57 | 4.47 |
Shares Outstanding Growth 5YR AVG | 48.96% | 28.76% |